• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估香港高血压或糖尿病或两者并存患者的 EQ-5D-5L 效用评分的最小重要差异:一项横断面研究。

Estimation of minimally important difference of the EQ-5D-5L utility scores among patients with either hypertension or diabetes or both: a cross-sectional study in Hong Kong.

机构信息

Centre for Health Systems and Policy Research, Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong SAR, China

Centre for Health Systems and Policy Research, Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong SAR, China.

出版信息

BMJ Open. 2020 Nov 26;10(11):e039397. doi: 10.1136/bmjopen-2020-039397.

DOI:10.1136/bmjopen-2020-039397
PMID:33243797
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7692985/
Abstract

OBJECTIVE

To estimate and report the minimally important difference (MID) of the EuroQol five-dimensional five-level questionnaire (EQ-5D-5L) using the Hong Kong (HK) utility score among patients with either hypertension or diabetes or both.

DESIGN

Data were analysed using secondary data analysis based on a cross-sectional study assessing patients' experiences in HK.

SETTING

A representative sample was recruited from 26 specialist outpatient clinics in HK.

PARTICIPANTS

We analysed data from 2231 and 662 patients who reported having hypertension or diabetes alone, respectively, and 874 patients had these two diseases.

INTERVENTION

An instrument-defined approach was applied to estimate MID stratified according to sex and age for the three subpopulations.

RESULTS

The overall MID (oMID) estimates were 0.089, 0.086 and 0.089 for patients with hypertension or diabetes alone and with these two diseases, respectively. The adjusted MID (aMID) estimate was smaller than the oMID, and the improved MID was larger than the deteriorated MID. Women had larger oMID but smaller aMID than men. Younger respondents had larger aMID than older respondents. Effect sizes ranged from 0.30 to 0.503, which fit our preset criteria.

CONCLUSION

Four types of MID of the EQ-5D utility score for patients with hypertension or diabetes alone and with these two diseases were reported. Variations in the MID estimates should be further explored in other populations or using different statistical methods.

摘要

目的

使用香港(HK)效用得分估计并报告欧洲五维健康量表五维问卷(EQ-5D-5L)在患有高血压或糖尿病或两者兼有患者中的最小重要差异(MID)。

设计

使用基于横断面研究评估患者在香港经历的二次数据分析数据。

设置

从香港 26 个专科门诊招募了一个代表性样本。

参与者

我们分析了分别报告患有高血压或糖尿病或同时患有这两种疾病的 2231 名和 662 名患者的数据,以及 874 名患有这两种疾病的患者的数据。

干预

根据三个亚组的性别和年龄,应用仪器定义方法估计 MID。

结果

患有高血压或糖尿病或同时患有这两种疾病的患者的总体 MID(oMID)估计值分别为 0.089、0.086 和 0.089。调整后的 MID(aMID)估计值小于 oMID,改善的 MID 大于恶化的 MID。女性的 oMID 大于男性,但 aMID 小于男性。年轻的受访者比年长的受访者有更大的 aMID。效应大小范围从 0.30 到 0.503,符合我们的预设标准。

结论

报告了单独患有高血压或糖尿病或同时患有这两种疾病的患者的 EQ-5D 效用评分的四种类型的 MID。应在其他人群或使用不同的统计方法中进一步探索 MID 估计值的变化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37d9/7692985/7088e5f01f23/bmjopen-2020-039397f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37d9/7692985/7088e5f01f23/bmjopen-2020-039397f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37d9/7692985/7088e5f01f23/bmjopen-2020-039397f01.jpg

相似文献

1
Estimation of minimally important difference of the EQ-5D-5L utility scores among patients with either hypertension or diabetes or both: a cross-sectional study in Hong Kong.评估香港高血压或糖尿病或两者并存患者的 EQ-5D-5L 效用评分的最小重要差异:一项横断面研究。
BMJ Open. 2020 Nov 26;10(11):e039397. doi: 10.1136/bmjopen-2020-039397.
2
Health-related quality of life among patients with hypertension: population-based survey using EQ-5D-5L in Hong Kong SAR, China.高血压患者的健康相关生活质量:中国香港特别行政区基于人群的 EQ-5D-5L 调查。
BMJ Open. 2019 Sep 27;9(9):e032544. doi: 10.1136/bmjopen-2019-032544.
3
Health-related quality of life in elderly people with hypertension and the estimation of minimally important difference using EQ-5D-5L in Hong Kong SAR, China.中国香港地区老年高血压患者的健康相关生活质量及使用 EQ-5D-5L 评估其最小重要差异。
Eur J Health Econ. 2020 Aug;21(6):869-879. doi: 10.1007/s10198-020-01178-9. Epub 2020 Apr 2.
4
Measurement of health-related quality of life in patients with diabetes mellitus using EQ-5D-5L in Hong Kong, China.中国香港地区使用 EQ-5D-5L 量表评估糖尿病患者的健康相关生命质量。
Qual Life Res. 2020 Jul;29(7):1913-1921. doi: 10.1007/s11136-020-02462-0. Epub 2020 Mar 5.
5
Minimally Important Difference of the EQ-5D-5L Index Score in Adults with Type 2 Diabetes.2 型糖尿病成人 EQ-5D-5L 指数评分的最小重要差异。
Value Health. 2018 Sep;21(9):1090-1097. doi: 10.1016/j.jval.2018.02.007. Epub 2018 Apr 4.
6
Measuring the impact of chronic conditions and associated multimorbidity on health-related quality of life in the general population in Hong Kong SAR, China: A cross-sectional study.测量中国香港特别行政区一般人群中慢性疾病及其相关多重疾病对健康相关生活质量的影响:一项横断面研究。
PLoS One. 2019 Nov 20;14(11):e0224970. doi: 10.1371/journal.pone.0224970. eCollection 2019.
7
Instrument-Defined Estimates of the Minimally Important Difference for EQ-5D-5L Index Scores.仪器定义的EQ-5D-5L指数得分最小重要差异估计值。
Value Health. 2017 Apr;20(4):644-650. doi: 10.1016/j.jval.2016.11.015. Epub 2017 Jan 10.
8
Estimation of an Instrument-Defined Minimally Important Difference in EQ-5D-5L Index Scores Based on Scoring Algorithms Derived Using the EQ-VT Version 2 Valuation Protocols.基于使用 EQ-VT 版本 2 估值协议推导的评分算法,估算 EQ-5D-5L 指数评分的仪器定义最小重要差异。
Value Health. 2020 Jul;23(7):936-944. doi: 10.1016/j.jval.2020.03.003. Epub 2020 May 14.
9
Examining the health-related quality of life using EQ-5D-5L in patients with four kinds of chronic diseases from specialist outpatient clinics in Hong Kong SAR, China.在中国香港特别行政区专科门诊就诊的四种慢性病患者中,使用EQ-5D-5L量表评估其健康相关生活质量。
Patient Prefer Adherence. 2017 Sep 12;11:1565-1572. doi: 10.2147/PPA.S143944. eCollection 2017.
10
Health-related quality of life measured using the EQ-5D-5L: South Australian population norms.使用EQ-5D-5L量表测量的健康相关生活质量:南澳大利亚州人群常模。
Health Qual Life Outcomes. 2016 Sep 20;14(1):133. doi: 10.1186/s12955-016-0537-0.

引用本文的文献

1
A systematic review of minimum important changes for generic multi-attribute utility instruments and recommendations for their estimation.通用多属性效用工具最小重要变化的系统评价及其估计建议。
Eur J Health Econ. 2025 Apr 16. doi: 10.1007/s10198-025-01778-3.
2
The psychometric properties of the amharic version of EuroQoL five-dimensions-five level among Ethiopian cervical cancer patients.埃塞俄比亚宫颈癌患者使用阿姆哈拉语版欧洲五维健康量表的心理测量特性。
Health Qual Life Outcomes. 2024 Nov 14;22(1):98. doi: 10.1186/s12955-024-02305-3.
3
Estimating the minimally important difference for the EQ-5D-5L and EORTC QLQ-C30 in cancer.

本文引用的文献

1
How is the minimal clinically important difference established in health-related quality of life instruments? Review of anchors and methods.健康相关生活质量量表中的最小临床重要差异是如何确定的?对锚定物和方法的综述。
Health Qual Life Outcomes. 2020 May 12;18(1):136. doi: 10.1186/s12955-020-01344-w.
2
Development and validation of a generic patient experience instrument for measuring specialist outpatient service in Hong Kong.开发和验证一种通用的患者体验工具,用于测量香港专科门诊服务。
Int J Qual Health Care. 2019 Dec 31;31(10):G158-G164. doi: 10.1093/intqhc/mzz113.
3
Measuring the impact of chronic conditions and associated multimorbidity on health-related quality of life in the general population in Hong Kong SAR, China: A cross-sectional study.
估算癌症患者 EQ-5D-5L 和 EORTC QLQ-C30 的最小重要差异。
Health Qual Life Outcomes. 2024 Sep 20;22(1):81. doi: 10.1186/s12955-024-02294-3.
测量中国香港特别行政区一般人群中慢性疾病及其相关多重疾病对健康相关生活质量的影响:一项横断面研究。
PLoS One. 2019 Nov 20;14(11):e0224970. doi: 10.1371/journal.pone.0224970. eCollection 2019.
4
Health-related quality of life among patients with hypertension: population-based survey using EQ-5D-5L in Hong Kong SAR, China.高血压患者的健康相关生活质量:中国香港特别行政区基于人群的 EQ-5D-5L 调查。
BMJ Open. 2019 Sep 27;9(9):e032544. doi: 10.1136/bmjopen-2019-032544.
5
Normative Profile of Health-Related Quality of Life for Hong Kong General Population Using Preference-Based Instrument EQ-5D-5L.采用偏好测量工具 EQ-5D-5L 对香港普通人群健康相关生命质量的规范化评估。
Value Health. 2019 Aug;22(8):916-924. doi: 10.1016/j.jval.2019.02.014. Epub 2019 Jul 27.
6
Health related quality of life in multimorbidity: a primary-care based study from Odisha, India.多病症患者的健康相关生活质量:来自印度奥里萨邦的一项基于初级保健的研究。
Health Qual Life Outcomes. 2019 Jul 5;17(1):116. doi: 10.1186/s12955-019-1180-3.
7
The prevalence of multimorbidity and associations with lifestyle factors among middle-aged Canadians: an analysis of Canadian Longitudinal Study on Aging data.中年加拿大人的多病共存率及其与生活方式因素的关联:对加拿大老龄化纵向研究数据的分析。
BMC Public Health. 2019 Feb 28;19(1):243. doi: 10.1186/s12889-019-6567-x.
8
Minimally Important Difference of the EQ-5D-5L Index Score in Adults with Type 2 Diabetes.2 型糖尿病成人 EQ-5D-5L 指数评分的最小重要差异。
Value Health. 2018 Sep;21(9):1090-1097. doi: 10.1016/j.jval.2018.02.007. Epub 2018 Apr 4.
9
Predicting health-related quality of life (EQ-5D-5 L) and capability wellbeing (ICECAP-A) in the context of opiate dependence using routine clinical outcome measures: CORE-OM, LDQ and TOP.运用常规临床结局评估工具(CORE-OM、LDQ 和 TOP)预测阿片类药物依赖患者的健康相关生活质量(EQ-5D-5L)和能力幸福感(ICECAP-A)
Health Qual Life Outcomes. 2018 May 30;16(1):106. doi: 10.1186/s12955-018-0926-7.
10
Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms.糖尿病、高血压和心血管疾病:临床见解与血管机制。
Can J Cardiol. 2018 May;34(5):575-584. doi: 10.1016/j.cjca.2017.12.005. Epub 2017 Dec 11.